International Journal of Radiation Oncology * Biology * Physics
Volume 65, Issue 5 , Pages 1315-1322 , 1 August 2006

Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers

  • Regiane S. Andrade, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • ,
  • Dwight E. Heron, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • Corresponding Author InformationReprint requests to: Dwight E. Heron, M.D., Department of Radiation Oncology, University of Pittsburgh Cancer Institute, 5150 Centre Avenue, No. 545, Pittsburgh, PA 15232. Tel: (412) 623-6723
    • ,
  • Berna Degirmenci, M.D.

      Affiliations

    • Division of Nuclear Medicine, Department of Radiology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • ,
  • Pedro A.A. Filho, M.D.

      Affiliations

    • Department of Otolaryngology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • ,
  • Barton F. Branstetter, M.D.

      Affiliations

    • Division of Neuroradiology, Department of Radiology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • Department of Otolaryngology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • ,
  • Raja R. Seethala, M.D.

      Affiliations

    • Department of Pathology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • ,
  • Robert L. Ferris, M.D., Ph.D.

      Affiliations

    • Department of Otolaryngology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    • ,
  • Norbert Avril, M.D.

      Affiliations

    • Division of Nuclear Medicine, Department of Radiology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States

Received 9 December 2005 ,Revised 9 March 2006 ,Accepted 9 March 2006.

References 

  1. Pfister DG , Shaha AR , Harrison LB . The role of chemotherapy in the curative treatment of head and neck cancer . Surg Oncol Clin N Am . 1997;6:749–768
  2. El-Sayed S , Nelson N . Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials . J Clin Oncol . 1996;14:838–847
  3. Ding M , Newman F , Raben D . New radiation therapy techniques for the treatment of head and neck cancer . Otolaryngol Clin North Am . 2005;38:371–395
  4. Dawson LA , Anzai Y , Marsh L , et al.   Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer . Int J Radiat Oncol Biol Phys . 2000;46:1117–1126
  5. Lee N , Xia P , Fischbein NJ , et al.   Intensity-modulated radiation therapy for head-and-neck cancer (The UCSF experience focusing on target volume delineation) . Int J Radiat Oncol Biol Phys . 2003;57:49–60
  6. Lin A , Kim HM , Terrell JE , et al.   Quality of life after parotid-sparing IMRT for head-and-neck cancer (A prospective longitudinal study) . Int J Radiat Oncol Biol Phys . 2003;57:61–70
  7. Paccagnella A , Orlando A , Marchiori C , et al.   Phase III trial of initial chemotherapy in Stage III or IV head and neck cancers (A study by the Gruppo di Studio sui Tumori della Testa e del Collo) . J Natl Cancer Inst . 1994;86:265–272
  8. Lefebvre JL , Chevalier D , Luboinski B , et al.  EORTC Head and Neck Cancer Cooperative Group   Larynx preservation in pyriform sinus cancer (Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial) . J Natl Cancer Inst . 1996;88:890–899
  9. Eisbruch A , Marsh LH , Dawson LA , et al.   Recurrences near base of skull after IMRT for head-and-neck cancer (Implications for target delineation in high neck and for parotid gland sparing) . Int J Radiat Oncol Biol Phys . 2004;59:28–42
  10. McCabe KJ , Rubinstein D . Advances in head and neck imaging . Otolaryngol Clin North Am . 2005;38:307–319
  11. Lowe VJ , Boyd JH , Dunphy FR , et al.   Surveillance for recurrent head and neck cancer using positron emission tomography . J Clin Oncol . 2000;18:651–658
  12. DiMartino E , Nowak B , Hassan HA , et al.   Diagnosis and staging of head and neck cancer (A comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings) . Arch Otolaryngol Head Neck Surg . 2000;126:1457–1461
  13. Menda Y , Graham MM . Update on (18)f-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers . Semin Nucl Med . 2005;35:214–219
  14. Townsend DW , Carney JP , Yap JT , et al.   PET/CT today and tomorrow . J Nucl Med . 2004;45:4S–14S
  15. Yeung HW , Schoder H , Smith A , et al.   Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography studies in cancer patients . Mol Imaging Biol . 2005;7:229–235
  16. Branstetter BFT , Blodgett TM , Zimmer LA , et al.   Head and neck malignancy (Is PET/CT more accurate than PET or CT alone?) . Radiology . 2005;235:580–586
  17. Greene FL , Page DL , Fleming ID , et al.   American Joint Committee on Cancer (AJCC Cancer staging manual) . 6th ed.. Philadelphia: Lippincott-Raven; 2002;
  18. Chao KS , Ozyigit G , Tran BN , et al.   Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer . Int J Radiat Oncol Biol Phys . 2003;55:312–321
  19. Fu KK , Pajak TF , Trotti A , et al.   A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas (First report of RTOG 9003) . Int J Radiat Oncol Biol Phys . 2000;48:7–16
  20. Avril NE , Weber WA . Monitoring response to treatment in patients utilizing PET . Radiol Clin North Am . 2005;43:189–204
  21. Mikhaeel NG , Timothy AR , O’Doherty MJ , et al.   18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin’s lymphoma—Comparison with CT . Leuk Lymphoma . 2000;39:543–553
  22. Spaepen K , Stroobants S , Dupont P , et al.   Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin’s lymphoma (Is [18F]FDG-PET a valid alternative to conventional diagnostic methods?) . J Clin Oncol . 2001;19:414–419
  23. Brucher B , Weber W , Bauer M , et al.   Neoadjuvant therapy of esophageal squamous cell carcinoma (Response evaluation by positron emission tomography) . Ann Surg . 2001;233:300–309
  24. Flamen P , VanCutsem E , Lerut A , et al.   Positron emission tomography for assessment of the response to induction chemotherapy in locally advanced esophageal cancer . Ann Oncol . 2002;13:361–368
  25. Berlangieri SU , Brizel DM , Scher RL , et al.   Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy . Head Neck . 1994;16:340–346
  26. Lowe VJ , Dunphy FR , Varvares M , et al.   Evaluation of chemotherapy response in patients with advanced head and neck cancer using [18F]fluorodeoxyglucose positron emission tomography . Head Neck . 1997;19:666–674
  27. Brun E , Kjellen E , Tennvall J , et al.   FDG PET studies during treatment (Prediction of therapy outcome in head and neck squamous cell carcinoma) . Head Neck . 2002;24:127–135
  28. Kostakoglu L , Goldsmith SJ . PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus . J Nucl Med . 2004;45:56–68
  29. McCollum AD , Burrell SC , Haddad RI , et al.   Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer . Head Neck . 2004;26:890–896
  30. Lehtio K , Eskola O , Viljanen T , et al.   Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer . Int J Radiat Oncol Biol Phys . 2004;59:971–982
  31. Nam SY , Lee SW , Im KC , et al.   Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET . Oral Oncol . 2005;41:390–395
  32. Sakamoto H , Nakai Y , Ohashi Y , et al.   Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas . Acta Otolaryngol Suppl . 1998;538:254–260
  33. Rogers JW , Greven KM , McGuirt WF , et al.   Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? . Int J Radiat Oncol Biol Phys . 2004;58:694–697
  34. Canellos GP . Residual mass in lymphoma may not be residual disease . J Clin Oncol . 1988;6:931–933
  35. Delbeke D , Martin WH . Positron emission tomography imaging in oncology . Radiol Clin North Am . 2001;39:883–917
  36. Greven KM , Williams DW , McGuirt WF , et al.   Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer . Head Neck . 2001;23:942–946
  37. Kunkel M , Forster GJ , Reichert TE , et al.   Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma . Oral Oncol . 2003;39:170–177
  38. Yao M , Graham MM , Smith RB , et al.   Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment (A preliminary report) . Int J Radiat Oncol Biol Phys . 2004;60:1410–1418
  39. Mendenhall WM , Villaret DB , Amdur RJ , et al.   Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck . Head Neck . 2002;24:1012–1018
  40. Frank DK , Hu KS , Culliney BE , et al.   Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer . Laryngoscope . 2005;115:1015–1020
  41. Peters LJ , Weber RS , Morrison WH , et al.   Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy . Head Neck . 1996;18:552–559
  42. Narayan K , Crane CH , Kleid S , et al.   Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy (For some or for all?) . Head Neck . 1999;21:606–613
  43. Yao M , Smith RB , Graham MM , et al.   The role of FDG pet in management of neck metastasis from head-and-neck cancer after definitive radiation treatment . Int J Radiat Oncol Biol Phys . 2005;12:12
  44. Porceddu SV , Jarmolowski E , Hicks RJ , et al.   Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer . Head Neck . 2005;27:175–181
  45. Avril N . GLUT1 expression in tissue and F-18 FDG uptake . J Nucl Med . 2004;45:930–932

PII: S0360-3016(06)00456-1

doi: 10.1016/j.ijrobp.2006.03.015

International Journal of Radiation Oncology * Biology * Physics
Volume 65, Issue 5 , Pages 1315-1322 , 1 August 2006

Article Tools

* Image Usage & Resolution